|
2019 Conference Publication Relating Airway Microbiota Composition to Nontuberculous Mycobacterial Infections in Adult Bronchiectasis PatientsThomson, R., Scoleri, G., Taylor, S., Leong, L., Burr, L. and Rogers, G. (2019). Relating Airway Microbiota Composition to Nontuberculous Mycobacterial Infections in Adult Bronchiectasis Patients. International Conference of the American-Thoracic-Society, Dallas Tx, May 17-22, 2019. NEW YORK: AMER THORACIC SOC. doi: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a1035 |
|
2017 Conference Publication AUDIT OF PRESCRIBING, MONITORING AND DOSAGE OF TOBRAMYCIN WITHIN A METROPOLITAN CYSTIC FIBROSIS UNITOlive, Gerard and Burr, Lucy (2017). AUDIT OF PRESCRIBING, MONITORING AND DOSAGE OF TOBRAMYCIN WITHIN A METROPOLITAN CYSTIC FIBROSIS UNIT. HOBOKEN: WILEY. |
|
2017 Conference Publication INFLIXIMAB FOR TREATMENT REFRACTORY SARCOIDOSIS, A CASE REPORT AND REVIEW OF LITERATUREOlive, Gerard and Burr, Lucy (2017). INFLIXIMAB FOR TREATMENT REFRACTORY SARCOIDOSIS, A CASE REPORT AND REVIEW OF LITERATURE. HOBOKEN: WILEY. |
|
2017 Conference Publication The Australasian Bronchiectasis Registry - Early Steps In Mapping The Impact Of Bronchiectasis In Australia And New ZealandVisser, S., Allan, H., Burr, L., Chang, A., Holmes-Liew, C. -L., Hunter, C., Jackson, D., King, P., Maguire, G., Middleton, P., Smith, D., Thomson, R., Waterer, G. W., Wong, C. and Morgan, L. (2017). The Australasian Bronchiectasis Registry - Early Steps In Mapping The Impact Of Bronchiectasis In Australia And New Zealand. International Conference of the American-Thoracic-Society (ATS), Washington Dc, May 19-24, 2017. NEW YORK: AMER THORACIC SOC. |
|
2017 Conference Publication The Australasian Bronchiectasis Registry - Early Steps in Mapping the Impact of Bronchiectasis in Australia and New ZealandVisser, Simone, Allan, Heather, Burr, Lucy, Chang, Anne, Holmes-Liew, Chien-Li, Hunter, Cameron, Jackson, Dan, King, Paul, Maguire, Graeme, Middleton, Peter, Smith, Daniel, Thomson, Rachel, Waterer, Grant, Wong, Conroy and Morgan, Lucy (2017). The Australasian Bronchiectasis Registry - Early Steps in Mapping the Impact of Bronchiectasis in Australia and New Zealand. The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting, Canberra, Australia, 24–28 March 2017. Richmond, VIC Australia: Wiley. |
|
2015 Conference Publication Spatial variation in the composition of infective lung microbiota revealed by 16S rRNA gene sequence analysis of multisite bronchoalveolar lavageScoleri, G., Leong, L., Burr, L., Choo, J., Thomson, R., Serisier, D. and Rogers, G. (2015). Spatial variation in the composition of infective lung microbiota revealed by 16S rRNA gene sequence analysis of multisite bronchoalveolar lavage. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science, Annual Scientific Meeting 2015, Gold Coast, Australia, 27 March – 1 April 2015. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12494_8 |
|
2015 Conference Publication Collagen protease levels vary with airway microbiota composition and lung function in bronchiectasisTaylor, S., Rogers, G., Chen, A., Burr, L., McGuckin, M. and Serisier, D. (2015). Collagen protease levels vary with airway microbiota composition and lung function in bronchiectasis. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science, Annual Scientific Meeting, Gold Coast, Australia, 27 March – 1 April 2015. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12495_14 |
|
2015 Conference Publication Sub inhibitory erythromycin reduces the expression of key P. aeruginosa virulence determinants in vitroBurr, L., Rogers, G., Taylor, S., McGuckin, M. and Serisier, D. (2015). Sub inhibitory erythromycin reduces the expression of key P. aeruginosa virulence determinants in vitro. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science, Annual Scientific Meeting, Gold Coast, Australia, 27 March – 1 April 2015. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12495_14 |
|
2015 Conference Publication Sub inhibitory erythromycin reduces the expression of key P. aeruginosa virulence determinants in non-CF bronchiectasis subjectsBurr, L., Rogers, G., Taylor, S., McGuckin, M. and Serisier, D. (2015). Sub inhibitory erythromycin reduces the expression of key P. aeruginosa virulence determinants in non-CF bronchiectasis subjects. Thoracic Society Australia New Zealand Australian New Zealand Society Respiratory Science Annual Scientific Meeting 2015, Queensland Australia, Mar 27-Apr 01, 2015. Hoboken, NJ United States: Wiley-Blackwell. |
|
2014 Conference Publication PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR Γ GENE EXPRESSION IN THE AIRWAYS OF NON CYSTIC FIBROSIS BRONCHIECTASIS SUBJECTS IS INVERSELY CORRELATED WITH TOTAL PSEUDOMONAS AERUGINOSA BACTERIAL LOAD BUT POSITIVELY CORRELATED WITH ABSOLUTE MACROPHAGE LEVELSBurr, L., Rogers, G., Chen, A. and Serisier, D. (2014). PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR Γ GENE EXPRESSION IN THE AIRWAYS OF NON CYSTIC FIBROSIS BRONCHIECTASIS SUBJECTS IS INVERSELY CORRELATED WITH TOTAL PSEUDOMONAS AERUGINOSA BACTERIAL LOAD BUT POSITIVELY CORRELATED WITH ABSOLUTE MACROPHAGE LEVELS. HOBOKEN: WILEY-BLACKWELL. |
|
2014 Conference Publication Clinical Benefits of Long-Term, Low-Dose Erythromycin in Bronchiectasis Are Not Due to Modulation of Sputum Mucin ContentChen, A., Martin, M., Lourie, R., Burr, L., Hasnain, S., Bowler, S., Mcguckin, M. and Serisier, D. (2014). Clinical Benefits of Long-Term, Low-Dose Erythromycin in Bronchiectasis Are Not Due to Modulation of Sputum Mucin Content. Annual Scientific Meeting of the Thoracic Society of Australia and New Zealand and the Australian and New Zealand Society of Respiratory Science 2014, Adelaide, SA Australia, 4-9 April 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12263_6 |
|
2014 Conference Publication Domination of the Lower Airway Microbiota by Veillonella Species Is Predictive of Frequent Exacerbation in Non-Cystic Fibrosis BronchiectasisRogers, G., Chen, A., Burr, L. and Serisier, D. (2014). Domination of the Lower Airway Microbiota by Veillonella Species Is Predictive of Frequent Exacerbation in Non-Cystic Fibrosis Bronchiectasis. Annual Scientific Meeting of the Thoracic Society of Australia and New Zealand and the Australian and New Zealand Society of Respiratory Science 2014, Adelaide, SA Australia, 4-9 April 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12262_10 |
|
2014 Conference Publication Human Neutrophil Elastase Activity and Matrix Metalloproteinase Activity Are Markers of Disease Severity in Non-Cf BronchiectasisChen, A., Lourie, R., Martin, M., Burr, L., Hasnain, S., Fantino, E., Bowler, S., Mcguckin, M. and Serisier, D. (2014). Human Neutrophil Elastase Activity and Matrix Metalloproteinase Activity Are Markers of Disease Severity in Non-Cf Bronchiectasis. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science 2014 Annual Scientific Meetings, Adelaide Australia, 4-9 April 2014. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12263_6 |
|
2014 Conference Publication Proportional Antimicrobial Susceptibility Testing of Whole Cystic Fibrosis Sputum-A Pilot StudyVisser, S., Burr, L., Rogers, G. and Serisier, D. (2014). Proportional Antimicrobial Susceptibility Testing of Whole Cystic Fibrosis Sputum-A Pilot Study. Annual Scientific Meeting of the Thoracic Society of Australia and New Zealand and the Australian and New Zealand Society of Respiratory Science 2014, Adelaide, SA Australia, 4-9 April 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12263_10 |
|
2013 Conference Publication Clinical Benefits Of Long-Term, Low-Dose Erythromycin In Bronchiectasis Are Not Due To Anti-Inflammatory EffectsChen, A. C., Martin, M. M., Burr, L., Hasnain, S. Z., Lourie, R., Bowler, S. D., McGuckin, M. A. and Serisier, D. J. (2013). Clinical Benefits Of Long-Term, Low-Dose Erythromycin In Bronchiectasis Are Not Due To Anti-Inflammatory Effects. American Thoracic Society 2013 International Conference, Philadelphia, PA, United States, 17-22 May 2013. New York, United States: American Thoracic Society. |
